Therakind Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Private

  • Employees
  • 11

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 2

Therakind General Information

Description

Operator of a specialty pharmaceutical company focused on developing niche medicines in difficult-to-treat markets, including pediatric and geriatric patient groups. The company's platform is designed to improve medicine adherence through more patient-friendly dosing options, enabling pharmaceutical companies to reach a wider range of patients and provide them with the treatment they need.

Contact Information

Website
www.therakind.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 314 Regents Park Road
  • Third Floor
  • London N3 2JX
  • England, United Kingdom
+44 020
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Vertical(s)
HealthTech
Corporate Office
  • 314 Regents Park Road
  • Third Floor
  • London N3 2JX
  • England, United Kingdom
+44 020

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Therakind Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Accelerator/Incubator 01-Sep-2025 Completed Generating Revenue
3. Secondary Transaction - Private Completed Generating Revenue
2. Early Stage VC 11-Jul-2007 $600K $600K Completed Startup
1. University Spin-Out 14-Jul-2006 Completed Startup
To view Therakind’s complete valuation and funding history, request access »

Therakind Patents

  • 32

    Total Documents Applications and Grants

  • Total Patents Families

  • 10

    Granted

  • 7

    Pending

  • Expiring in next 12 mo

Therakind Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202403611-D0 Improved multi-dose medicament delivery device Inactive 13-Mar-2024
WO-2025191263-A1 Improved multi-dose medicament delivery device Pending 13-Mar-2024
GB-202315801-D0 Antimicrobial use of annexin a1 protein Inactive 16-Oct-2023
WO-2025083394-A1 Antimicrobial use of annexin a1 protein Inactive 16-Oct-2023
GB-202315799-D0 Antimicrobial use of peptides derived from annexin a1 Inactive 16-Oct-2023
To view Therakind’s complete patent history, request access »

Therakind Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Therakind Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Grow London Accelerator/Incubator
University College London University
To view Therakind’s complete investors history, request access »

Ready to get started?

Request a free trial

Therakind FAQs

  • When was Therakind founded?

    Therakind was founded in 2006.

  • Where is Therakind headquartered?

    Therakind is headquartered in London, United Kingdom.

  • What is the size of Therakind?

    Therakind has 11 total employees.

  • What industry is Therakind in?

    Therakind’s primary industry is Drug Discovery.

  • Is Therakind a private or public company?

    Therakind is a Private company.

  • What is Therakind’s current revenue?

    The current revenue for Therakind is .

  • How much funding has Therakind raised over time?

    Therakind has raised $600K.

  • Who are Therakind’s investors?

    Grow London and University College London have invested in Therakind.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process